DongKook Pharmaceutical Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2018 - 2014
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2018 - 2014
Operating Revenue	764,673	730,994	661,647	594,193	559,103	482,280	Upgrade
Other Revenue	-	-	-0	-	-	-	Upgrade
Revenue	764,673	730,994	661,647	594,193	559,103	482,280	Upgrade
Revenue Growth (YoY)	10.38%	10.48%	11.35%	6.28%	15.93%	20.33%	Upgrade
Cost of Revenue	337,346	320,443	281,999	244,272	221,983	191,808	Upgrade
Gross Profit	427,327	410,551	379,648	349,921	337,120	290,473	Upgrade
Selling, General & Admin	316,313	310,542	277,684	257,570	227,646	198,319	Upgrade
Research & Development	27,439	25,456	21,818	24,691	18,859	19,890	Upgrade
Other Operating Expenses	1,217	1,278	1,350	887.7	732.4	744.73	Upgrade
Operating Expenses	352,756	343,677	306,107	286,702	254,518	221,754	Upgrade
Operating Income	74,571	66,873	73,541	63,219	82,602	68,718	Upgrade
Interest Expense	-5,644	-5,868	-4,320	-2,883	-1,796	-618.99	Upgrade
Interest & Investment Income	6,179	5,258	2,903	2,454	2,709	2,371	Upgrade
Earnings From Equity Investments	-608.8	-896.71	1,122	1,031	451.62	-758.83	Upgrade
Currency Exchange Gain (Loss)	16.19	-65.38	708.54	2,657	-2,980	1,409	Upgrade
Other Non Operating Income (Expenses)	-1,888	596.82	-603.97	932.71	-2,834	2,132	Upgrade
EBT Excluding Unusual Items	72,625	65,898	73,350	67,411	78,152	73,252	Upgrade
Gain (Loss) on Sale of Investments	-4,287	-5,814	-5,337	1,376	1,881	2,719	Upgrade
Gain (Loss) on Sale of Assets	2,897	752.89	618.82	966.3	-2.32	-341.3	Upgrade
Pretax Income	71,235	60,838	68,632	69,754	80,031	75,629	Upgrade
Income Tax Expense	15,933	11,966	13,876	16,837	22,150	16,579	Upgrade
Earnings From Continuing Operations	55,302	48,871	54,757	52,916	57,880	59,050	Upgrade
Minority Interest in Earnings	-809.76	-1,696	-1,861	-2,571	-1,955	-2,738	Upgrade
Net Income	54,492	47,175	52,896	50,345	55,925	56,312	Upgrade
Net Income to Common	54,480	47,175	52,896	50,345	55,925	56,312	Upgrade
Net Income Growth	15.55%	-10.82%	5.07%	-9.98%	-0.69%	19.94%	Upgrade
Shares Outstanding (Basic)	44	44	44	44	44	44	Upgrade
Shares Outstanding (Diluted)	45	45	45	45	45	45	Upgrade
Shares Change (YoY)	0.02%	0.02%	0.01%	-	-	0.94%	Upgrade
EPS (Basic)	1239.21	1073.13	1203.46	1145.56	1272.52	1281.33	Upgrade
EPS (Diluted)	1218.48	1055.00	1183.00	1126.00	1251.00	1259.00	Upgrade
EPS Growth	15.52%	-10.82%	5.06%	-9.99%	-0.64%	18.80%	Upgrade
Free Cash Flow	8,705	7,616	-7,005	-6,352	19,502	44,352	Upgrade
Free Cash Flow Per Share	194.60	170.27	-156.64	-142.04	436.09	991.79	Upgrade
Dividend Per Share	180.000	180.000	-	-	-	-	Upgrade
Gross Margin	55.88%	56.16%	57.38%	58.89%	60.30%	60.23%	Upgrade
Operating Margin	9.75%	9.15%	11.11%	10.64%	14.77%	14.25%	Upgrade
Profit Margin	7.12%	6.45%	7.99%	8.47%	10.00%	11.68%	Upgrade
Free Cash Flow Margin	1.14%	1.04%	-1.06%	-1.07%	3.49%	9.20%	Upgrade
EBITDA	99,070	87,971	92,728	80,577	97,714	82,334	Upgrade
EBITDA Margin	12.96%	12.03%	14.01%	13.56%	17.48%	17.07%	Upgrade
D&A For EBITDA	24,500	21,098	19,187	17,358	15,112	13,616	Upgrade
EBIT	74,571	66,873	73,541	63,219	82,602	68,718	Upgrade
EBIT Margin	9.75%	9.15%	11.11%	10.64%	14.77%	14.25%	Upgrade
Effective Tax Rate	22.37%	19.67%	20.22%	24.14%	27.68%	21.92%	Upgrade
Advertising Expenses	-	76,804	66,472	67,064	58,171	54,381	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.